Department of Pathology & Laboratory Medicine.
James P. Wilmot Cancer Institute.
Am J Surg Pathol. 2022 Dec 1;46(12):1682-1687. doi: 10.1097/PAS.0000000000001939. Epub 2022 Aug 2.
The prognosis of prostate cancers exhibiting extraprostatic extension [other than bladder or seminal vesicle invasion (EPE)] and/or microscopic bladder neck invasion (mBNI) is variable, and further risk stratification is required. We herein assessed radical prostatectomy findings and long-term oncologic outcomes in consecutive 957 patients with pT3a disease. The patient cohort was divided into 4 groups, focal EPE (F-EPE) only (n=177; 18.5%), nonfocal/established (E-EPE) only (n=634; 66.2%), mBNI only (n=51; 5.3%). The rate of positive surgical margin and estimated volume of tumor were significantly higher in patients with both EPE and mBNI than in those with either. In addition, compared with F-EPE or mBNI only, E-EPE only was significantly associated with higher Grade Group, lymph node metastasis, and larger tumor volume. Kaplan-Meier analysis revealed a comparable prognosis after prostatectomy between those showing F-EPE only versus mBNI only ( P =0.986), and these 2 cohorts were combined for further analysis. Then, patients showing E-EPE only had a significantly higher or lower risk of progression compared with those showing F-EPE or mBNI only ( P <0.001) or both EPE and mBNI ( P <0.001), respectively. These significant differences in progression-free survival were also seen in subgroups, including those with or without undergoing adjuvant therapy before recurrence and those showing no lymph node metastasis. In multivariate analysis, F-EPE or mBNI only (hazard ratio=0.524, P =0.003) or both EPE and mBNI (hazard ratio=1.465, P =0.039) (vs. E-EPE only) showed significance for progression. Based on these findings, we propose a novel pT3a subclassification, pT3a1 (F-EPE or mBNI alone), pT3a2 (E-EPE alone), and pT3a3 (both EPE and mBNI).
前列腺癌伴有前列腺外延伸[非膀胱或精囊侵犯(EPE)]和/或显微镜下膀胱颈侵犯(mBNI)的预后是可变的,需要进一步进行风险分层。在此,我们评估了连续 957 例 pT3a 疾病患者的根治性前列腺切除术结果和长期肿瘤学结果。将患者队列分为 4 组,局限性 EPE(F-EPE)仅(n=177;18.5%)、非局限性/广泛的 EPE(E-EPE)仅(n=634;66.2%)、mBNI 仅(n=51;5.3%)。与仅 EPE 阳性或 mBNI 阳性相比,同时存在 EPE 和 mBNI 的患者的切缘阳性率和肿瘤估计体积显著更高。此外,与仅 F-EPE 或 mBNI 阳性相比,仅 E-EPE 阳性与更高的分级分组、淋巴结转移和更大的肿瘤体积显著相关。Kaplan-Meier 分析显示,仅 F-EPE 与仅 mBNI 的患者在前列腺切除术后的预后相当(P=0.986),将这两组合并进行进一步分析。然后,与仅 F-EPE 或 mBNI 阳性或两者均阳性的患者相比,仅 E-EPE 阳性的患者的进展风险显著更高或更低(P<0.001)。在亚组分析中,包括在复发前接受辅助治疗和未发生淋巴结转移的患者中,也观察到无进展生存率的显著差异。在多变量分析中,仅 F-EPE 或 mBNI(风险比=0.524,P=0.003)或同时存在 EPE 和 mBNI(风险比=1.465,P=0.039)(与仅 E-EPE 阳性相比)对进展有显著意义。基于这些发现,我们提出了一种新的 pT3a 亚分类,pT3a1(仅 F-EPE 或 mBNI)、pT3a2(仅 E-EPE)和 pT3a3(同时存在 EPE 和 mBNI)。